{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:30:52Z","timestamp":1764783052042},"reference-count":13,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["YAKUGAKU ZASSHI"],"published-print":{"date-parts":[[2008,4,1]]},"DOI":"10.1248\/yakushi.128.663","type":"journal-article","created":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T05:49:44Z","timestamp":1207288184000},"page":"663-666","source":"Crossref","is-referenced-by-count":13,"title":["Effect of Tetrandrine Combined with Epirubicin on the Growth of Human Breast Carcinoma Multidrug Resistance Cell Line"],"prefix":"10.1248","volume":"128","author":[{"given":"Yue","family":"HOU","sequence":"first","affiliation":[{"name":"Shenyang Pharmaceutical University"},{"name":"General Hospital of Shenyang Military Region"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"GUO","sequence":"additional","affiliation":[{"name":"General Hospital of Shenyang Military Region"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfu","family":"WU","sequence":"additional","affiliation":[{"name":"Shenyang Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"HE","sequence":"additional","affiliation":[{"name":"General Hospital of Shenyang Military Region"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ling V., <i>Cancer Chemother. Pharmacol.<\/i>, <b>40<\/b> (Suppl.), S3-10 (1997).","DOI":"10.1007\/s002800051053"},{"key":"2","unstructured":"2) Szabo D., Keyzer H., Kaiser H. E., Molnar J., <i>Anticancer Res.<\/i>, <b>20<\/b>, 4261-4274 (2000)."},{"key":"3","unstructured":"3) Motoji T., Motomura S., Wang Y. H., <i>Int. J. Hematol.<\/i>, <b>72<\/b>, 418-424 (2000)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) van den Heuvel-Eibrink M. M., Sonneveld P., Pieters R., <i>Int. J. Clin. Pharmacol. Ther.<\/i>, <b>38<\/b>, 94-110 (2000).","DOI":"10.5414\/CPP38094"},{"key":"5","unstructured":"5) Scheper R. J., Broxterman H. J., Scheer G. L., Kaaijk P., Dalton W. S., van Heijningen T. H., van Kalken C. K., Slovak M. L., de Vries E. G., van der Valk P., <i>Cancer Res.<\/i>, <b>53<\/b>, 1475-1479 (1993)."},{"key":"6","unstructured":"6) Volm M., <i>Anticancer Res.<\/i>, <b>18<\/b>, 2905-2917 (1998)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Malayeri R., Filipits M., Suchomel R. W., Zochbauer S., Lechner K., Pirker R. <i>Leuk. Lymphoma.<\/i>, <b>23<\/b>, 451-458 (1996).","DOI":"10.3109\/10428199609054853"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Krishna R., Mayer L. D., <i>Eur. J. Pharm. Sci.<\/i>, <b>11<\/b>, 265-283 (2000).","DOI":"10.1016\/S0928-0987(00)00114-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sikic B. I., Fisher G. A., Lum B. L., Halsey J., Beketic-Oreskovic L., Chen G., <i>Cancer Chemother. Pharmacol.<\/i>, <b>40<\/b> (Suppl.), S13-19 (1997).","DOI":"10.1007\/s002800051055"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Liu Z. L., Hirano T., Tanaka S., Onda K., Oka K., <i>J. Pharm. Pharmacol.<\/i>, <b>55<\/b>, 1531-1537 (2003).","DOI":"10.1211\/0022357022115"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Fu L., Liang Y., Deng L., Ding Y., Chen L., Ye Y., Yang X., Pan Q., <i>Cancer Chemother. Pharmacol.<\/i>, <b>53<\/b>, 349-356 (2004).","DOI":"10.1007\/s00280-003-0742-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Fu L. W., Zhang Y. M., Liang Y. J., Yang X. P., Pan Q. C., <i>Eur. J. Cancer<\/i>, <b>38<\/b>, 418-426 (2002).","DOI":"10.1016\/S0959-8049(01)00356-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hou Y., Guo T., Wu C. F., He X., Zhao M. H., <i>Yakugaku Zasshi<\/i>, <b>126<\/b>, 1383-1386 (2006).","DOI":"10.1248\/yakushi.126.1383"}],"container-title":["YAKUGAKU ZASSHI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/128\/4\/128_4_663\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T09:36:58Z","timestamp":1536399418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/128\/4\/128_4_663\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1248\/yakushi.128.663","relation":{},"ISSN":["0031-6903","1347-5231"],"issn-type":[{"value":"0031-6903","type":"print"},{"value":"1347-5231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,1]]}}}